临床表型和病理生理机制是潜在的定性低VWF
Ferdows Atiq1, Robin Blok2, Calvin van Kwawegen3
1Erasmus MC, Netherlands.
Blood
|April 25, 2025
概括
·维勒布兰德因子 (VWF) 活性中的轻度功能缺陷,称为低VWF-QL,是常见的,并导致显著的出血. 与2型VWD相比,这些患者具有明显的临床特征.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 遗传学 遗传学是一种遗传学.
背景情况:
- 一些患有低·维勒布兰德因子 (VWF) 和出血的患者具有正常的VWF抗原水平,但VWF活性降低 (30-50 IU/dL).
- 这些案例代表了"质量"低的VWF,不同于定量VWF缺陷.
- 在这些患者中轻度功能性VWF缺陷的临床意义尚未明确.
研究的目的:
- 调查具有质性低VWF (低VWF-QL) 的患者轻度功能VWF缺陷的临床影响.
- 为了确定低VWF-QL是否是一个独特的临床实体.
- 探索低VWF-QL的潜在机制.
主要方法:
- 来自爱尔兰队列的低VWF和Erasmus MC研究中的低VWF的综合数据.
- 分析了VWF活动和VWF抗原水平.
- 评估出血表型和研究VWF序列变异.
主要成果:
- 低VWF-QL约占低VWF组合的50%左右.
- 许多低VWF-QL (VWF活性30-50 IU/dL) 的患者表现出显著的出血,尽管VWF抗原水平正常.
- 与2型VWD相比,低VWF-QL被确定为一个独特的临床病理实体.
- VWF-QL主要是由内皮细胞中的VWF生物合成异常引起的,在很大程度上独立于序列变异.
结论:
- 在30-50 IU/dL范围内轻度的功能性VWF缺陷具有临床意义,并与出血有关.
- 低VWF-QL是一种与2型VWD不同的情况.
- 在VWF生物合成中的异常是低VWF-QL的可能原因.
- 这些发现对诊断和管理轻度功能VWF缺陷的患者有意义.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
532
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
532
Disorders of Hemostasis
638
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
638
Extrinsic and Intrinsic Pathways of Hemostasis
3.5K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
3.5K
Clot Retraction and Fibrinolysis
2.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
2.4K
Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
Pleiotropy
37.6K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
37.6K


